Bluelinx Holdings Inc

BXC has formed an early Stage 1 consolidation after a steep decline, punctuated by a Momentum Breakout above prior resistance and the 9/20 EMAs. This pattern signals new demand and supports a bullish medium-term bias, but price is currently extended above short-term EMAs and overbought on key indicators. Patience is warranted for a pullback into the breakout zone around the 9/20 EMA cluster before committing to a long entry.

• ↑Q1 2026 revenue reached $731 M (+3% YoY) led by DeStero specialty sales
• ↑Adjusted EBITDA rose 20% YoY to $23.5 M via cost controls and volume gains
• ↓Gross margin only 15.9%; price deflation cut into specialty and structural segments